BRAF and melanoma: It is interesting to note that several studies also suggest the relevance of combined inhibition of CRAF and BRAF in a BRAF mutant context for efficacy and may prove to be relevant strategy for treatment of both NRAS and BRAF mutant melanomas [34], [35].